Therapeutic tyrosine kinase inhibitors for multiple sclerosis
TW202626042APending Publication Date: 2026-07-01PRINCIPIA BIOPHARMA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114132845
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-08-11
- Filing Date
- 2025-08-28
- Publication Date
- 2026-07-01
Abstract
This disclosure relates to the field of therapeutic tyrosine kinase inhibitors, in particular, Bruton tyrosine kinase (“BTK”) inhibitors, for treatment of patients with multiple sclerosis (MS).
Need to check novelty before this filing date? Find Prior Art